Atera Closes €1.2M Equity Funding Round

atera-logoAtera S.A., a Luxembourg-based tissue engineering company, closed a €1.2m equity funding round.

Backers included private individuals with a experience in life science business and startup funding.

The company intends to use the funding to further commercialize its existing portfolio of human tissue models and expand related research.

Led by Dr. Bart De Wever, CEO, Atera specializes in research and development, validation, manufacturing and commercialization of advanced human tissue models to address the demand for high-quality test methods for product evaluation, gradually reducing and replacing animal experimentation, for both industrial safety & efficacy testing as well as medical research.

A follow up round of equity funding is planned to develop the company’s contract research activities and initiate the commercialization of the recently acquired mini brain technology.



Join the discussion